Small Cell Lung Cancer | Lung Cancer Nursing UK

Small Cell Lung Cancer

Thursday 22nd May, 18:00 - 19:00

Joining us for our fifth webinar of the year is Dr Adam Uprichard, Medical Oncology Consultant based in Northern Ireland, who is going to share with us an update on Small Cell Lung Cancer.

Webinar objectives:

  • Overview of the current treatment pathways for limited stage and extensive stage SCLC
  • Update on recent developments in systemic therapies
  • Managing treatment-related side effects
  • Explore future directions for treatment 

All healthcare professionals are welcome to join this webinar and to participate in the Q&A session that will follow the presentation.

This webinar programme has been instigated by Lung Cancer Nursing UK. Sponsorship has been received by AstraZeneca UK Ltd to support the costs of this webinar series.  AstraZeneca has had no input into the development of topics, selection of speakers or the content of the webinars

If you wish to learn more about AstraZeneca’s lung cancer brands please reach out to your local AstraZeneca Oncology Account Manager.

Speakers

  • Adam Uprichard

    Dr Adam Uprichard obtained his undergraduate degree from Queen’s University Belfast in 2008 and then worked within different centres in Northern Ireland before obtaining membership of the Royal College of Physicians in 2015. He then began specialist training in medical oncology at the Northern Ireland Cancer Centre, Belfast where he worked as a registrar until he completed his training in 2020.

    Dr Uprichard currently works as a medical oncology consultant between NI Cancer Centre and Craigavon Area Hospital, specialising in the systemic treatment of lung and GU cancers. He has a particular interest in targeted agents as well as immunotherapy.

  • Emma Halkyard

    The Christie NHS Foundation Trust
    I’ve worked as an oncology nurse for more than 20 years: since 2014 as an Advanced Nurse Practitioner in the lung cancer team at The Christie Hospital in Manchester. I’m highly motivated and enthusiastic. I’m keen to push the boundaries of specialist nursing, having set up a nurse-led clinic for mutation-driven lung cancer and currently in the process of establishing a regional small cell lung cancer service to enable rapid access to treatments with the aim of achieving ambitious national standards (GIRFT and NLCA). I am co-chair of the Nurse subgroup of the Greater Manchester Lung Cancer Pathway Board and have an interest in driving strategic change to improve outcomes for patients as well as advocating for lung nurses in the region. I have a special interest in mutation-driven lung cancer, raising awareness of never-smoker lung cancer, improving access to treatments for small cell lung cancer, nurse-led services and nurse leadership in the MDT.